Find Clinical Trial

Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure


← Back
Study Phase

Phase 2

Therapeutic Area

Cardiovascular Diseases

IndicationHeart failure
SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active substance/
Medical device

IVABRADINE,
S016257

Active Substance CodeS016257
Protocol CodeCL2-16257-053
NCT CodeNCT00202579


Documents and links

Results summary READ MORE




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility